Drive payer submission readiness for Phase 2 and 3 product

Session addresses the challenges of implementing autologous/allogeneic cell gene therapies into scalable networks.

Allen Jacques explains the history behind medications’ lack of supply, while offering ways to help alleviate their impact.

Masterclass session addresses looking beyond a dashboard by added capabilities with added value.

Brandon Newman joins The Pharmaceutical Commerce Podcast to discuss the evolving role of PBMs, including the importance of drug price transparency.

If manufacturers cannot ensure safe, cost-effective delivery of treatments for rare diseases, access will remain a challenges for many patients living with these conditions.

The program recognizes organizations that prioritize the highest standards of care when it comes to the handling and transportation of goods in the healthcare space.